Neonatal Group B Streptococcus Disease

Area of Science:

• Neonatal health
• Infectious disease epidemiology
• Microbial pathogenesis

Background:

• Group B Streptococcus (GBS) is a leading cause of sepsis in newborns.
• Vertical transmission from mother to infant during birth is a primary concern.
• Current prevention strategies include antepartum screening and intrapartum antibiotic prophylaxis.

Approach:

• Reviewing contemporary epidemiology and pathogenesis of neonatal GBS disease.
• Summarizing obstetric recommendations for antenatal screening and intrapartum antibiotic prophylaxis.
• Examining antibiotic selection and national guidelines for infant risk assessment and management.

Key Points:

• Despite prevention efforts, neonatal GBS disease remains a significant threat, causing mortality and morbidity.
• Antenatal GBS screening and intrapartum antibiotic prophylaxis have decreased GBS disease incidence.
• Understanding GBS epidemiology, pathogenesis, and clinical presentation is crucial for effective management.

Conclusions:

• Neonatal GBS disease prevention requires ongoing adherence to screening and prophylaxis guidelines.
• Effective management involves careful risk assessment and timely intervention for at-risk infants.
• Further research may elucidate novel strategies to combat persistent GBS infections.